CytoMed Therapeutics Limited (GDTC)
NASDAQ: GDTC · Real-Time Price · USD
0.900
-0.080 (-8.16%)
At close: Apr 28, 2026, 4:00 PM EDT
0.997
+0.097 (10.78%)
Pre-market: Apr 29, 2026, 8:23 AM EDT
CytoMed Therapeutics Market Cap
CytoMed Therapeutics has a market cap or net worth of $10.65 million as of April 29, 2026. Its market cap has decreased by -63.09% in one year.
Market Cap
10.65M
Enterprise Value
9.40M
1-Year Change
-63.09%
Ranking
Category
Stock Price
$0.90
Market Cap Chart
Since the IPO on April 14, 2023, CytoMed Therapeutics's market cap has decreased from $46.12M to $10.65M, a decrease of -76.91%. That is a compound annual growth rate of -38.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 10.65M | -30.87% |
| Dec 31, 2025 | 15.41M | -60.74% |
| Dec 31, 2024 | 39.24M | -30.55% |
| Dec 29, 2023 | 56.49M | 22.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioCardia | 12.58M |
| BioVie | 12.44M |
| Cyclerion Therapeutics | 12.28M |
| CDT Equity | 12.00M |
| Traws Pharma | 11.57M |
| Cellectar Biosciences | 11.51M |
| Enveric Biosciences | 11.30M |
| Lunai Bioworks | 11.29M |